Jinxin Fertility Group akcijos akcijų analizė | Akcijų kaina | Naujienos | 1951.HK | KYG5140J1013 | A2PL6U

Data	Jinxin Fertility Group Akcijų kaina
2024-09-20	2,10 undefined
2024-09-19	2,07 undefined
2024-09-17	1,98 undefined
2024-09-16	1,98 undefined
2024-09-13	2,00 undefined
2024-09-12	1,99 undefined
2024-09-11	2,00 undefined
2024-09-10	2,01 undefined
2024-09-09	2,03 undefined
2024-09-05	2,03 undefined
2024-09-04	2,02 undefined
2024-09-03	2,05 undefined
2024-09-02	2,02 undefined
2024-08-30	2,16 undefined
2024-08-29	2,23 undefined
2024-08-28	2,19 undefined
2024-08-27	2,24 undefined
2024-08-26	2,23 undefined
2024-08-23	2,22 undefined

Data	Jinxin Fertility Group Pajamos	Jinxin Fertility Group EBIT	Jinxin Fertility Group Pelnas
2029e	7,25 mlrd. undefined	0 undefined	0 undefined
2028e	6,51 mlrd. undefined	1,59 mlrd. undefined	0 undefined
2027e	5,77 mlrd. undefined	1,39 mlrd. undefined	0 undefined
2026e	4,28 mlrd. undefined	839,87 mln. undefined	637,48 mln. undefined
2025e	3,73 mlrd. undefined	724,61 mln. undefined	532,68 mln. undefined
2024e	3,25 mlrd. undefined	627,44 mln. undefined	460,25 mln. undefined
2023	2,79 mlrd. undefined	508,16 mln. undefined	344,72 mln. undefined
2022	2,36 mlrd. undefined	262,52 mln. undefined	121,12 mln. undefined
2021	1,84 mlrd. undefined	400,76 mln. undefined	339,90 mln. undefined
2020	1,43 mlrd. undefined	237,53 mln. undefined	251,62 mln. undefined
2019	1,65 mlrd. undefined	544,88 mln. undefined	409,62 mln. undefined
2018	921,99 mln. undefined	305,70 mln. undefined	166,60 mln. undefined
2017	662,77 mln. undefined	241,53 mln. undefined	98,78 mln. undefined
2016	346,41 mln. undefined	106,45 mln. undefined	87,58 mln. undefined

	Pajamos	EBIT	Pelnas
2016	346,41 mln. CNY	106,45 mln. CNY	87,58 mln. CNY
2017	662,77 mln. CNY	241,53 mln. CNY	98,78 mln. CNY
2018	921,99 mln. CNY	305,70 mln. CNY	166,60 mln. CNY
2019	1,65 mlrd. CNY	544,88 mln. CNY	409,62 mln. CNY
2020	1,43 mlrd. CNY	237,53 mln. CNY	251,62 mln. CNY
2021	1,84 mlrd. CNY	400,76 mln. CNY	339,90 mln. CNY
2022	2,36 mlrd. CNY	262,52 mln. CNY	121,12 mln. CNY
2023	2,79 mlrd. CNY	508,16 mln. CNY	344,72 mln. CNY
2024e	3,25 mlrd. CNY	627,44 mln. CNY	460,25 mln. CNY
2025e	3,73 mlrd. CNY	724,61 mln. CNY	532,68 mln. CNY
2026e	4,28 mlrd. CNY	839,87 mln. CNY	637,48 mln. CNY
2027e	5,77 mlrd. CNY	1,39 mlrd. CNY	0 CNY
2028e	6,51 mlrd. CNY	1,59 mlrd. CNY	0 CNY
2029e	7,25 mlrd. CNY	0 CNY	0 CNY

2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e
0,35	0,66	0,92	1,65	1,43	1,84	2,36	2,79	3,25	3,73	4,28	5,77	6,51	7,25
-	91,33	39,12	78,94	−13,47	28,89	28,62	17,94	16,64	14,67	14,86	34,72	12,77	11,34
38,15	45,62	44,84	49,51	39,62	41,95	36,97	42,14	-	-	-	-	-	-
0,13	0,30	0,41	0,82	0,57	0,77	0,87	1,18	0	0	0	0	0	0
0,11	0,24	0,31	0,54	0,24	0,40	0,26	0,51	0,63	0,72	0,84	1,39	1,59	0
30,64	36,40	33,12	33,01	16,62	21,76	11,08	18,22	19,28	19,42	19,59	24,04	24,47	-
87,00	98,00	166,00	409,00	251,00	339,00	121,00	344,00	460,00	532,00	637,00	0	0	0
-	12,64	69,39	146,39	−38,63	35,06	−64,31	184,30	33,72	15,65	19,74	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-
0,07	0,58	1,13	2,21	2,42	2,50	2,62	2,74	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-

2016	2017	2018	2019	2020	2021	2022	2023

0,19	0,45	1,25	0,63	0,74	1,93	1,40	0,85
2,90	66,72	76,92	46,06	68,75	64,33	83,32	73,09
0	0	71,83	57,83	88,57	452,86	286,47	273,12
12,75	18,69	16,55	26,08	25,48	46,81	62,55	62,43
0	0	0,02	2,66	1,72	0,05	0,07	0,08
0,21	0,53	1,44	3,43	2,65	2,54	1,90	1,34
0,05	0,12	0,14	1,03	1,28	1,49	3,10	3,12
0	0	9,99	10,02	180,44	353,17	131,00	271,58
0	125,35	438,17	0	61,91	209,51	39,20	56,80
0	0,66	3,63	3,66	3,88	5,21	6,20	6,21
0	0,20	0,80	0,81	0,89	2,72	3,48	3,50
500,97	100,46	102,08	12,34	219,62	300,05	373,39	394,79
0,55	1,20	5,12	5,52	6,51	10,28	13,33	13,55
0,76	1,74	6,56	8,94	9,16	12,83	15,23	14,90

60,20	688,27	0,13	0,16	0,16	0,17	0,17	0,18
0	0	4,31	6,99	6,80	7,89	7,88	8,90
0,02	0,24	0,05	0,47	0,78	1,11	0,89	1,26
0	0	0	67,26	−301,96	−454,37	−129,47	−74,93
0	0	0	0	0	−3,89	0	0
0,08	0,93	4,36	7,53	7,28	8,55	8,64	10,09
0,03	0,05	0,14	0,11	0,12	0,15	0,22	1,04
18,27	65,84	151,51	124,86	117,75	157,81	199,41	164,47
0,61	0,08	1,08	0,17	0,26	0,67	0,44	0,32
0	0	0	0	0	0	0	0
0	0	0	0,03	0,05	0,10	1,91	0,98
0,65	0,20	1,38	0,44	0,56	1,07	2,76	2,49
0	0	0	0,15	0,35	1,99	2,55	1,81
0	0,17	0,68	0,71	0,79	1,01	1,19	1,21
0	0	4,77	0	0	0	0	0
0	0,17	0,68	0,86	1,15	3,00	3,73	3,02
0,65	0,38	2,06	1,30	1,70	4,07	6,50	5,51
0,73	1,30	6,42	8,83	8,98	12,62	15,14	15,61

2016	2017	2018	2019	2020	2021	2022
109,00	241,00	276,00	547,00	349,00	457,00	154,00
14,00	35,00	42,00	112,00	130,00	169,00	261,00
0	0	0	0	0	0	0
−11,00	−229,00	46,00	−199,00	−158,00	−292,00	−11,00
−2,00	0	−9,00	−8,00	−12,00	8,00	137,00
17,00	0	0	9,00	13,00	20,00	87,00
0	21,00	35,00	125,00	51,00	47,00	122,00
108,00	47,00	356,00	452,00	308,00	343,00	541,00
−8,00	−32,00	−20,00	−60,00	−323,00	−79,00	−959,00
−608,00	−252,00	−388,00	−2 705,00	−130,00	−1 566,00	−1 377,00
−600,00	−219,00	−367,00	−2 645,00	192,00	−1 486,00	−418,00
0	0	0	0	0	0	0
0,03	0	0	−0,03	0,14	−0,03	1,32
0	0	1,13	3,08	−0,06	1,01	0,08
0,66	0,46	0,77	1,65	−0,06	0,96	0,46
635,00	463,00	−22,00	−1 075,00	18,00	−26,00	−781,00
0	0	−342,00	−327,00	−149,00	0	−158,00
163,00	258,00	735,00	−604,00	101,00	−275,00	−359,00
100,97	15,48	335,46	392,10	−15,33	263,62	−417,65
0	0	0	0	0	0	0

Jinxin Fertility Group Bruto marža	Jinxin Fertility Group Pelnas-martža	Jinxin Fertility Group EBIT marža	Jinxin Fertility Group Pelnas-martža
2029e	42,15 %	0 %	0 %
2028e	42,15 %	24,47 %	0 %
2027e	42,15 %	24,04 %	0 %
2026e	42,15 %	19,61 %	14,88 %
2025e	42,15 %	19,43 %	14,28 %
2024e	42,15 %	19,29 %	14,15 %
2023	42,15 %	18,22 %	12,36 %
2022	36,98 %	11,10 %	5,12 %
2021	41,96 %	21,79 %	18,48 %
2020	39,67 %	16,66 %	17,64 %
2019	49,55 %	33,05 %	24,85 %
2018	44,81 %	33,16 %	18,07 %
2017	45,59 %	36,44 %	14,90 %
2016	38,31 %	30,73 %	25,28 %

	Bruto marža	EBIT marža	Pelnas-martža
2016	38,31 %	30,73 %	25,28 %
2017	45,59 %	36,44 %	14,90 %
2018	44,81 %	33,16 %	18,07 %
2019	49,55 %	33,05 %	24,85 %
2020	39,67 %	16,66 %	17,64 %
2021	41,96 %	21,79 %	18,48 %
2022	36,98 %	11,10 %	5,12 %
2023	42,15 %	18,22 %	12,36 %
2024e	42,15 %	19,29 %	14,15 %
2025e	42,15 %	19,43 %	14,28 %
2026e	42,15 %	19,61 %	14,88 %
2027e	42,15 %	24,04 %	0 %
2028e	42,15 %	24,47 %	0 %
2029e	42,15 %	0 %	0 %

Data	Jinxin Fertility Group Pardavimai vienai akcijai	Jinxin Fertility Group EBIT vienai akcijai	Jinxin Fertility Group Pelnas vienai akcijai
2029e	2,69 undefined	0 undefined	0 undefined
2028e	2,42 undefined	0 undefined	0 undefined
2027e	2,14 undefined	0 undefined	0 undefined
2026e	1,59 undefined	0 undefined	0,24 undefined
2025e	1,38 undefined	0 undefined	0,20 undefined
2024e	1,21 undefined	0 undefined	0,17 undefined
2023	1,02 undefined	0,19 undefined	0,13 undefined
2022	0,90 undefined	0,10 undefined	0,05 undefined
2021	0,73 undefined	0,16 undefined	0,14 undefined
2020	0,59 undefined	0,10 undefined	0,10 undefined
2019	0,75 undefined	0,25 undefined	0,19 undefined
2018	0,82 undefined	0,27 undefined	0,15 undefined
2017	1,15 undefined	0,42 undefined	0,17 undefined
2016	5,11 undefined	1,57 undefined	1,29 undefined

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2016	5,11 CNY	1,57 CNY	1,29 CNY
2017	1,15 CNY	0,42 CNY	0,17 CNY
2018	0,82 CNY	0,27 CNY	0,15 CNY
2019	0,75 CNY	0,25 CNY	0,19 CNY
2020	0,59 CNY	0,10 CNY	0,10 CNY
2021	0,73 CNY	0,16 CNY	0,14 CNY
2022	0,90 CNY	0,10 CNY	0,05 CNY
2023	1,02 CNY	0,19 CNY	0,13 CNY
2024e	1,21 CNY	0 CNY	0,17 CNY
2025e	1,38 CNY	0 CNY	0,20 CNY
2026e	1,59 CNY	0 CNY	0,24 CNY
2027e	2,14 CNY	0 CNY	0 CNY
2028e	2,42 CNY	0 CNY	0 CNY
2029e	2,69 CNY	0 CNY	0 CNY

	Akcijų skaičius
2016	67,80 mln. Aktien
2017	578,20 mln. Aktien
2018	1,13 mlrd. Aktien
2019	2,21 mlrd. Aktien
2020	2,42 mlrd. Aktien
2021	2,50 mlrd. Aktien
2022	2,62 mlrd. Aktien
2023	2,74 mlrd. Aktien
2024e	2,74 mlrd. Aktien
2025e	2,74 mlrd. Aktien
2026e	2,74 mlrd. Aktien
2027e	2,74 mlrd. Aktien
2028e	2,74 mlrd. Aktien
2029e	2,74 mlrd. Aktien

Data	Jinxin Fertility Group Dividendas
2022	0,07 undefined
2020	0,07 undefined

	Dividendas	Dividenda (įvertinimas)
2016	0 CNY	0 CNY
2017	0 CNY	0 CNY
2018	0 CNY	0 CNY
2019	0 CNY	0 CNY
2020	0,07 CNY	0 CNY
2021	0 CNY	0 CNY
2022	0,07 CNY	0 CNY
2023	0 CNY	0 CNY
2024e	0 CNY	0 CNY
2025e	0 CNY	0 CNY
2026e	0 CNY	0 CNY
2027e	0 CNY	0 CNY
2028e	0 CNY	0 CNY
2029e	0 CNY	0 CNY

Data	Jinxin Fertility Group Išmokėjimo santykis
2029e	123,47 %
2028e	124,86 %
2027e	124,68 %
2026e	120,86 %
2025e	129,04 %
2024e	124,13 %
2023	109,42 %
2022	153,56 %
2021	109,42 %
2020	65,28 %
2019	109,42 %
2018	109,42 %
2017	109,42 %
2016	109,42 %

	Išmokėjimo santykis
2016	109,42 %
2017	109,42 %
2018	109,42 %
2019	109,42 %
2020	65,28 %
2021	109,42 %
2022	153,56 %
2023	109,42 %
2024e	124,13 %
2025e	129,04 %
2026e	120,86 %
2027e	124,68 %
2028e	124,86 %
2029e	123,47 %

%	Pavadinimas	Akcijos	Pokytis	Data
6,54010 %	HHLR Advisors, Ltd.	176 181 349	−10 682 000	2023-01-16
11,85922 %	JINXIN Fertility Investment Group Ltd.	319 471 061	0	2023-01-16
10,71250 %	HRC Investment Holding, LLC	288 580 005	−8 343 570	2023-01-16
1,80505 %	The Vanguard Group, Inc.	48 625 676	0	2024-03-31
1,29591 %	Bosera Asset Management Co., Ltd.	34 910 000	8 520 500	2023-12-31
1,06764 %	Norges Bank Investment Management (NBIM)	28 760 883	−2 731 892	2023-12-31
0,75936 %	BlackRock Institutional Trust Company, N.A.	20 456 160	706 500	2024-03-31
0,42687 %	BlackRock Investment Management (UK) Ltd.	11 499 313	1 020 608	2022-07-21
0,41518 %	BlackRock Asset Management Ireland Limited	11 184 500	164 500	2022-07-20
0,39269 %	Penghua Fund Management Co., Ltd.	10 578 549	366 500	2023-12-31
0,39111 %	China Asset Management Co., Ltd.	10 536 000	5 382 000	2023-12-31
0,36915 %	E Fund Management Co. Ltd.	9 944 500	2 243 000	2023-12-31
0,34870 %	China Universal Asset Management Co., Ltd.	9 393 500	−11 969 500	2023-12-31
0,34390 %	British Columbia Investment Management Corp.	9 264 165	8 734 184	2023-03-31
0,34170 %	Bank of Communications Schroder Fund Management Co., Ltd.	9 204 910	0	2023-12-31
0,33597 %	HuaAn Fund Management Co., Ltd.	9 050 500	−2 169 500	2023-06-30
0,24792 %	Dong (Yang)	6 678 500	1 203 500	2024-01-05
0,24344 %	Lyu (Rong)	6 558 000	1 054 000	2023-04-06
0,24129 %	Zhong (Yong CPA)	6 500 000	1 000 000	2023-04-04
0,24105 %	Focusbridge Investments Limited	6 493 500	−226 000	2023-06-30
0,23761 %	Barings (U.K.) Limited	6 401 000	0	2023-12-31
0,23515 %	Pictet Asset Management Ltd.	6 334 500	0	2023-09-30
0,23403 %	American Century Investment Management, Inc.	6 304 500	271 500	2024-03-31
0,21480 %	BlackRock Advisors (UK) Limited	5 786 500	31 500	2024-03-31
0,21413 %	Dimensional Fund Advisors, L.P.	5 768 500	231 000	2024-02-29
0,19470 %	Huashang Fund Management Co., Ltd.	5 245 000	2 490 500	2023-12-31
0,18223 %	China Southern Asset Management Co. Ltd.	4 909 000	1 240 500	2023-12-31
0,14190 %	State Street Global Advisors (US)	3 822 676	−75 000	2024-03-31
0,12822 %	Dimensional Fund Advisors, Ltd.	3 454 000	559 000	2024-02-29
0,12592 %	Fullgoal Asset Management (HK) Limited	3 392 000	3 392 000	2022-12-31
0,12100 %	BlackRock (Luxembourg) S.A.	3 259 500	−45 965 939	2022-07-14
0,11196 %	Yan (Xiaoqing)	3 016 000	800 000	2024-01-26
0,10838 %	ZhongGeng Fund Management Co., Ltd.	2 919 500	0	2023-06-30
0,09061 %	BlackRock Japan Co., Ltd.	2 441 000	−4 028 722	2022-07-14
0,09052 %	HSBC JinTrust Fund Management Co., Ltd.	2 438 500	1 193 000	2023-12-31
0,08909 %	BlackRock (Netherlands) B.V.	2 400 000	−11 921 861	2022-07-06
0,08882 %	Fullgoal Fund Management Co., Ltd.	2 392 631	1 308 500	2023-12-31
0,08286 %	CCB Principal Asset Management Co., Ltd.	2 232 000	1 830 000	2023-06-30
0,08233 %	Charles Schwab Investment Management, Inc.	2 217 803	0	2024-03-31
0,07166 %	State Street Global Advisors (UK) Ltd.	1 930 530	3	2024-03-31
0,07090 %	China Asset Management (Hong Kong) Limited	1 909 874	−118 000	2024-03-31
0,06439 %	Tianhong Asset Management Co., Ltd.	1 734 500	1 734 500	2023-06-30
0,06118 %	Hwabao WP Fund Management Co., Ltd.	1 648 000	67 000	2023-12-31
0,05559 %	Nuveen LLC	1 497 500	0	2024-03-31
0,05457 %	PGGM Vermogensbeheer B.V.	1 469 947	38 490	2023-07-31
0,03571 %	Geode Capital Management, L.L.C.	962 000	0	2024-02-29
0,03254 %	Fideuram Asset Management (Ireland) dac	876 500	0	2024-02-29
0,03179 %	Yinhua Fund Management Co., Ltd.	856 500	557 000	2023-12-31
0,02825 %	Zhong Ou Asset Management Co., Ltd.	761 000	−17 120 902	2023-06-30
0,02738 %	Value Partners Ltd.	737 500	0	2023-12-31
0,02715 %	Nikko Asset Management Asia Limited	731 500	−121 000	2023-09-30
0,02704 %	HSBC Global Asset Management (UK) Limited	728 506	−17 580	2024-02-29
0,02402 %	Truvalue Asset Management Co., Ltd.	647 000	418 000	2023-06-30
0,02238 %	Trilogy Global Advisors, LP	603 000	−122 500	2022-10-31
0,02227 %	Voya Investment Management LLC	600 000	600 000	2023-02-28
0,02012 %	State Street Global Advisors Ireland Limited	542 000	27 000	2024-03-31
0,01980 %	Topsperity Fund Management Co., Ltd.	533 500	533 500	2023-06-30
0,01949 %	Franklin Advisers, Inc.	525 000	273 000	2024-03-31
0,01938 %	Swedbank Robur Fonder AB	522 000	0	2024-02-29
0,01726 %	Avantis Investors	465 000	0	2024-03-31
0,01523 %	Legal & General Investment Management Ltd.	410 307	0	2024-02-29
0,01485 %	GF Securities Asset Management (Guangdong) Co., Ltd.	400 000	400 000	2023-06-30
0,01394 %	Sectoral Asset Management Inc.	375 400	−75 000	2024-02-29
0,01262 %	Great Wall Fund Management Co., Ltd.	340 000	−234 500	2023-06-30
0,00965 %	Van Eck Associates Corporation	260 000	−5 730 000	2023-06-30
0,00891 %	Xinghua Fund Management Co., Ltd.	240 000	104 000	2023-06-30
0,00880 %	BlackRock Asset Management North Asia Limited	237 000	0	2023-12-31
0,00779 %	DFA Australia Ltd.	209 786	106 286	2023-12-31
0,00743 %	China Merchants Fund Management Co. Ltd.	200 174	200 174	2023-06-30
0,00729 %	Vanguard Global Advisers LLC	196 500	2 500	2024-02-29
0,00622 %	Vanguard Investments Australia Ltd.	167 520	257	2024-02-29
0,00601 %	Ping An Fund Management Company Limited	162 000	47 500	2023-06-30
0,00601 %	Scottish Equity Partners LLP	162 000	0	2024-02-29
0,00558 %	Credit Suisse Funds AG	150 289	−1 653 500	2022-12-31
0,00506 %	Asset Management One Co., Ltd.	136 249	103 501	2022-11-30
0,00388 %	Franklin Advisory Services, LLC	104 500	4 500	2024-03-31
0,00353 %	Guotai Asset Management Co., Ltd.	95 000	−237 000	2023-12-31
0,00310 %	Storebrand Kapitalforvaltning AS	83 500	0	2024-02-29
0,00275 %	Franklin Templeton Portfolio Advisors, Inc	74 000	0	2022-08-31
0,00273 %	Northern Trust Investments, Inc.	73 500	0	2024-03-31
0,00262 %	Allianz Global Investors Asia Pacific Limited	70 500	0	2024-02-29
0,00260 %	ZhongRong Fund Mgmt Co., Ltd	70 000	−1 537 500	2023-06-30
0,00251 %	Essence Fund Management Co., Ltd.	67 500	−13 500	2023-12-31
0,00217 %	Nomura Asset Management Co., Ltd.	58 364	0	2022-12-31
0,00190 %	TimesSquare Capital Management, LLC	51 050	0	2024-02-29
0,00186 %	Deka International S.A.	50 000	50 000	2023-02-28
0,00186 %	INVESCO Great Wall Fund Management Co. Ltd.	50 000	50 000	2023-12-31
0,00169 %	Mitsubishi UFJ Kokusai Asset Management Co., Ltd.	45 580	−21 687	2022-12-31
0,00156 %	Shanghai Haitong Securities Asset Management Ltd.	42 000	42 000	2023-06-30
0,00139 %	Cinda Fund Management Co., Ltd.	37 500	−12 500	2023-12-31
0,00120 %	GVC Gaesco Gestión SGIIC S.A.	32 394	−156	2023-12-31
0,00110 %	GF Fund Management Co., Ltd.	29 500	0	2023-12-31
0,00056 %	Morgan Stanley Investment Management (China) Company Limited.	15 000	15 000	2023-06-30
0,00052 %	RBC Indigo Asset Management Inc.	14 000	0	2022-07-31
0,00051 %	Invesco Capital Management LLC	13 760	9 000	2024-03-31
0,00043 %	Hang Seng Investment Management Ltd.	11 500	−714 000	2023-06-30
0,00026 %	Hongde Fund Management Co., Ltd.	7 000	−1 536 500	2023-06-30
0,00020 %	Krane Funds Advisors, LLC	5 500	0	2023-09-30
0,00009 %	Chang Xin Asset Management Co., Ltd.	2 500	2 500	2023-06-30
0,00002 %	Eurizon Capital S.A.	656	0	2024-02-29

What values and corporate philosophy does Jinxin Fertility Group represent?

Jinxin Fertility Group Ltd is dedicated to providing reliable and innovative reproductive healthcare solutions. With a strong commitment to ethical practices, they prioritize patient safety and satisfaction. Jinxin Fertility Group Ltd's corporate philosophy revolves around promoting and advancing fertility treatments, ensuring accessibility and affordability for couples seeking infertility care. By combining cutting-edge technology with personalized care, they aim to achieve high success rates in assisted reproductive technology procedures. Jinxin Fertility Group Ltd values integrity, professionalism, and excellence in delivering comprehensive fertility services, fostering hope, and making dreams of starting a family come true.

In which countries and regions is Jinxin Fertility Group primarily present?

Jinxin Fertility Group Ltd is primarily present in China.

What significant milestones has the company Jinxin Fertility Group achieved?

Jinxin Fertility Group Ltd has achieved several significant milestones. Firstly, the company successfully listed on the Stock Exchange of Hong Kong in 2018, marking a major achievement in its growth trajectory. Additionally, Jinxin Fertility Group Ltd has expanded its presence by opening multiple fertility treatment centers across China, solidifying its position as a leading provider of reproductive health services in the country. The company has also achieved noteworthy advancements in technology and research, consistently introducing innovative techniques and treatments to enhance patient outcomes. With its commitment to excellence and continuous development, Jinxin Fertility Group Ltd has established itself as a prominent player in the fertility industry.

What is the history and background of the company Jinxin Fertility Group?

Jinxin Fertility Group Ltd is a leading company in the fertility industry. Established in XXXX, it has quickly gained prominence for its innovative fertility treatments and advanced technology. With a wide range of services including in-vitro fertilization (IVF), preimplantation genetic diagnosis (PGD), and reproductive surgery, Jinxin Fertility Group Ltd has successfully helped countless individuals and couples achieve their dream of parenthood. The company is known for its state-of-the-art facilities and highly skilled medical professionals who are dedicated to providing personalized care and support throughout the journey to conception. As a trusted name in the field, Jinxin Fertility Group Ltd continues to revolutionize the fertility industry and bring hope to those struggling with infertility.

Who are the main competitors of Jinxin Fertility Group in the market?

The main competitors of Jinxin Fertility Group Ltd in the market include other prominent players in the fertility services industry, such as Hangzhou Tigermed Consulting Co., Ltd, New Hope Fertility Co., Ltd, and Merck KGaA. These competitors possess similar expertise in the field of assisted reproductive technology and offer comparable services to individuals and couples seeking fertility treatments. By constantly innovating and delivering high-quality fertility solutions, Jinxin Fertility Group Ltd strives to maintain a competitive edge in the market against these key rivals.

In which industries is Jinxin Fertility Group primarily active?

Jinxin Fertility Group Ltd is primarily active in the healthcare and fertility industry.

What is the business model of Jinxin Fertility Group?

The business model of Jinxin Fertility Group Ltd revolves around providing comprehensive fertility services and solutions. Jinxin Fertility Group Ltd specializes in offering a wide range of assisted reproductive technology (ART) services, including in vitro fertilization (IVF), genetic testing, and fertility preservation. The company's goal is to assist individuals and couples in overcoming fertility challenges and achieving their dream of starting a family. Jinxin Fertility Group Ltd is committed to delivering high-quality, personalized care to its patients, supported by a team of experienced fertility specialists and state-of-the-art facilities. Its business model combines medical expertise, advanced technology, and compassionate care to meet the diverse needs of its clients.

Koks yra Jinxin Fertility Group 2024 KGV?

Jinxin Fertility Group KGV yra 12,48.

Koks Jinxin Fertility Group 2024 KUV?

Jinxin Fertility Group KUV yra 1,77.

Koks yra Jinxin Fertility Group AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis Jinxin Fertility Group yra 3/10.

Koks yra Jinxin Fertility Group 2024 pajamų dydis?

tikėtina Jinxin Fertility Group pardavimai yra 3,25 mlrd. CNY.

Kokia yra Jinxin Fertility Group 2024 pelnas?

tikėtina Jinxin Fertility Group pelnas yra 460,25 mln. CNY.

Ką daro Jinxin Fertility Group?

Jinxin Fertility Group Ltd is an internationally recognized clinic group specializing in reproductive medicine. With comprehensive medical expertise, the latest treatment technologies, and a respectful approach to patients' individual needs, Jinxin Fertility has become a leading service provider in this field. An important part of Jinxin Fertility Group's business model is to offer high-quality services and products that meet the needs of patients in different income groups. This includes a wide range of treatments and procedures, from basic consultations to complex invasive techniques such as in-vitro fertilization (IVF). In addition to fertility treatment, Jinxin Fertility Group also offers other services, including preventive healthcare, cosmetic gynecology, and medical tourism. Patients from around the world come to avail themselves of the services of Jinxin Fertility Group. There has been an increase in the number of patients, particularly from Asian countries such as Japan, Korea, Vietnam, and Thailand. But European and American patients are also increasingly choosing the group's services. The group has a very large network of internationally recognized specialists in the field of reproductive medicine. The doctors and medical staff are highly qualified and have extensive experience. They work with state-of-the-art technology and utilize the latest innovations in fertility treatment. Jinxin Fertility Group also offers special programs for couples experiencing difficulty in achieving pregnancy, such as the "Baby Now" program. This is a customized package of IVF treatment. The program includes comprehensive pre-examinations, individual treatment with cutting-edge technologies and medications, as well as continuous monitoring and a special care program. Another important component of Jinxin Fertility Group's business model is to continue developing new methods and treatments through medical progress and research to increase the chances of successful pregnancy. The group collaborates with leading research institutes and specialized institutions around the world. Overall, Jinxin Fertility Group is an established and successful clinic group with a comprehensive range of services and products in the field of reproductive medicine. The group is focused on a broad national and international customer portfolio and offers a comprehensive program of research, diagnostics, and treatment. Its goal is always to maximize the chances of pregnancy for each individual patient.

Kokia yra Jinxin Fertility Group dividendė?

Jinxin Fertility Group moka dividendą 0,07 CNY, kuris yra paskirstytas per išmokas per metus.

Kiek kartų Jinxin Fertility Group moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota Jinxin Fertility Group arba įmonė dividendų nemoka.

Kas yra Jinxin Fertility Group ISIN?

Jinxin Fertility Group ISIN yra KYG5140J1013.

Kas yra Jinxin Fertility Group WKN?

Jinxin Fertility Group WKN yra A2PL6U.

Kas yra Jinxin Fertility Group Tickeris?

Jinxin Fertility Group akcijų simbolis yra 1951.HK.

Kiek dividendų moka Jinxin Fertility Group?

Per paskutinius 12 mėnesių Jinxin Fertility Group išmokėjo dividendą, kurios dydis siekė 0,07 CNY . Tai atitinka maždaug 3,52 % dividendų grąžą. Artimiausiems 12 mėnesiams Jinxin Fertility Group tikėtina išmokės dividendus, kurie sudarys 0 CNY.

Kokia yra Jinxin Fertility Group dividendų grąža?

Jinxin Fertility Group šiuo metu yra 3,52 % dydžio dividendų grąža.

Kada Jinxin Fertility Group moka dividendus?

Jinxin Fertility Group moka dividendus kas ketvirtį. Jie išmokami rugpjūtis, liepa, liepa, rugpjūtis mėnesiais.

Kokia saugi yra Jinxin Fertility Group dividendų išmokėjimas?

Jinxin Fertility Group per paskutiniuosius 0 metus kiekvienais metais mokėjo dividendus.

Kokia yra Jinxin Fertility Group dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0 CNY. Tai atitinka 0 % dividendų grąžos procentą.

Kokiame sektoriuje yra Jinxin Fertility Group?

Jinxin Fertility Group priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von Jinxin Fertility Group kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį Jinxin Fertility Group dividendą nuo 2024-07-25, kurio dydis yra 0,01 CNY, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-07-01.

Kada Jinxin Fertility Group paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-07-25.

Kokia buvo Jinxin Fertility Group dividendų suma 2023 metais?

2023 metais Jinxin Fertility Group išmokėjo 0,074 CNY dividendų.

Kokia valiuta Jinxin Fertility Group moka dividendus?

Jinxin Fertility Group dividendai yra mokami CNY.

Tiesioginiai išleidimai	1 457,98
Netiesioginės emisijos iš įsigytos energijos	12 118,4
Tiesioginiai išmetimai iš vertybių grandinės	—
CO₂ emisijos	13 576,4
CO₂ mažinimo strategija	✅
Anglies energija	❌
Atomkraft	❌
Bandymai su gyvūnais	❌
Pelz & Leder	—
Pesticidai	—
Palmių aliejus	—
Tabakas	❌
Genetinė inžinerija	❌
Klimato koncepcija	—
Tvarioji miškininkystė	—
Perdirbimo nuostatai	❌
Aplinkai draugiška pakuotė	❌
Pavojingosios medžiagos	✅
Degalų sąnaudos ir efektyvumas	✅
Vandens suvartojimas ir efektyvumas	✅

Moterų dalis tarp darbuotojų	85,466
Moterų dalis valdyme	—
Azijietiškų darbuotojų dalis	—
Akcijų dalis Azijos valdyme	—
Hispanų/lotynų kilmės darbuotojų dalis	—
Hispanų/latino kilmės vadybos dalis	—
Akcijų turimų tamsios odos darbuotojų procentas	—
Juodaodžių valdymo dalis	—
Baltųjų darbuotojų dalis	—
Baltųjų valdymo dalis	—
Suaugusiųjų turinys	❌
Alkoholis	❌
Ginkluotė	—
Šaunamieji ginklai	❌
Azartiniai lošimai	❌
Karinių sutarčių	❌
Žmogaus teisių koncepcija	✅
Privatumo politika	—
Darbo ir sveikatos apsauga	✅
Katalikiškas	✅

Tvarumo ataskaita	✅
Akcijų turėtojų įtraukimas	✅
Atsiliepimo taisyklės	❌
Kartelio teisė	❌

Birža	Jinxin Fertility Group Akcijų kodas
DIUSELDORFAS	3NX.DU
FRANKFURTAS	3NX.F
HKSE	1951.HK
MIUNCHENAS	3NX.MU
PNK	JXFGF

Jinxin Fertility Group Akcijų kodas	Jinxin Fertility Group FIGI
1951:HK	BBG00PBQF9Z0
3NX:GR	BBG00PK21WC2
3NX:GF	BBG00PK21WD1
3NX:GD	BBG00PK21WF9
3NX:GS	BBG00PK21WH7
3NX:GM	BBG00PK21WJ5
3NX:TH	BBG00PLY4MP6
3NX:QT	BBG00PPP44G1
1951:H2	BBG00Q6WBFY2
JXFGF:US	BBG00RP1H7S6
JXFGF:PQ	BBG00RP1H868
JXFGF:UV	BBG00RP1H877
1951HKD:EP	BBG00TYGW4S9
1951HKD:EZ	BBG00TYGW4V5
3NX:GZ	BBG00W9LMK95
3NX:LA	BBG018H9RSV8
3NX:LU	BBG018J3FBM9

Padaryk geriausias savo gyvenimo investicijas fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kursas

Akcijos kaina

Akcijų kodas1951.HK

ISINKYG5140J1013

VVPA2PL6U

Jinxin Fertility Group akcijų kaina

Kursas

Apžvalga

Intraday funkcija

Bendroji grąža ir santykinė kainų pokyčiai

Interpretacija ir investavimas

Jinxin Fertility Group Akcijų istorija

Jinxin Fertility Group akcijų apyvarta, EBIT, pelnas KYG5140J1013 · A2PL6U

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

Jinxin Fertility Group Pajamų, pelno ir EBIT istorija.

Jinxin Fertility Group Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

Jinxin Fertility Group Akcijos Maržos KYG5140J1013 · A2PL6U

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

Jinxin Fertility Group Maržų istorija

Jinxin Fertility Group akcijos apyvarta, EBIT, pelnas vienai akcijai KYG5140J1013 · A2PL6U

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Jinxin Fertility Group Pardavimų, pelno ir EBIT istorija vienai akcijai

Jinxin Fertility Group akcija ir akcijų analizė

Jinxin Fertility Group vertinimas pagal Fair Value

Fair Value

Supratimas apie Fair Value

Pajamų pagrindu skaičiuojamas Fair Value

Apyvartos pagrindu skaičiuojamas Fair Value

Dividendų pagrindu skaičiuojamas Fair Value

Lūkesčiai ir prognozės

Palyginamoji analizė

Jinxin Fertility Group įvertinimas pagal istorinį P/E, EBIT ir P/S

Jinxin Fertility Group akcijų skaičius KYG5140J1013 · A2PL6U

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Jinxin Fertility Group akcijos dividendas KYG5140J1013 · A2PL6U

Dividendas

Dividendų apžvalga

Interpretacija ir naudojimas

Investavimo strategija

Jinxin Fertility Group Dividendų istorija

Jinxin Fertility Group akcijų išmokėjimo koeficientas KYG5140J1013 · A2PL6U

Dividendų mokėjimo rodiklis

Kas yra metinis dividendų mokėjimo rodiklis?

Kaip interpretuoti duomenis

Duomenų naudojimas investavimui

Jinxin Fertility Group Dividendų išmokėjimo istorija

Jinxin Fertility Group Pelno prognozės

Padaryk geriausias savo gyvenimo investicijas
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Akcijų kodas
1951.HK

ISIN
KYG5140J1013

VVP
A2PL6U